Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration-Reference-Cited by-同舟云学术

Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration

Published:2004-06 Issue:2 Volume:174 Page:275-285
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Trocho Carme,Escolà-Gil Joan Carles,Ribas Vicent,Benı́tez Sònia,Martı́n-Campos Jesús M,Rotllan Noemi,Osaba Lourdes,Ordóñez-Llanos Jordi,González-Sastre Francesc,Blanco-Vaca Francisco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy;Boden;Am J Cardiol,2000

2. Why not phenytoin?;Lane;Am J Cardiol,2000

3. Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study;Muuronen;Br Med J,1985

4. A prospective, randomized trial of phenytoin in nonepileptic subjects with reduced HDL cholesterol;Miller;Arterioscler Thromb. Vasc Biol,1995

5. Effects of phenytoin on plasma high-density lipoprotein cholesterol levels in men with low levels of high-density lipoprotein cholesterol;Goerdt;J Clin Pharmacol,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Voltage-gated sodium channel inhibitor reduces atherosclerosis by modulating monocyte/macrophage subsets and suppressing macrophage proliferation;Biomedicine & Pharmacotherapy;2019-12

2. Comorbidities in Epilepsy: Range and Impact;Epilepsy and the interictal state;2015-07-31

3. Atherogenic consequence of antiepileptic drugs: a study of intima-media thickness;Neurological Sciences;2013-07-13

4. Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients;Seizure;2013-03

5. CETP activity variation in mice does not affect two major HDL antiatherogenic properties: Macrophage-specific reverse cholesterol transport and LDL antioxidant protection;Atherosclerosis;2008-02